Functional activities of mutant calcium-sensing receptors determine clinical presentations in patients with autosomal dominant hypocalcemia

Journal of Clinical Endocrinology and Metabolism

Volumn 99, Issue 2, 2014, Pages

  Kinoshita, Yuka ^a   Hori, Michiko ^a   Taguchi, Manabu ^a   Watanabe, Sumiyo ^a   Fukumoto, Seiji ^a  

^a UNIVERSITY OF TOKYO HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; CALCIUM; CHILD; FEMALE; HUMANS; HYPERCALCIURIA; HYPOCALCEMIA; HYPOPARATHYROIDISM; MAGNESIUM; MALE; MIDDLE AGED; MUTATION; PARATHYROID HORMONE; PHENOTYPE; RECEPTORS, CALCIUM-SENSING;

EID: 84893763038     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.2013-3430     Document Type: Article

References (21)

1. Pollak MR, Brown EM, Estep HL, et al. Autosomal dominant hypocalcaemia caused by a Ca(2-)-sensing receptor gene mutation. Nat Genet. 1994;8:303-307.
2. Brown EM, Gamba G, Riccardi D, et al. Cloning and characterization of an extracellular Ca(2-)-sensing receptor from bovine parathyroid. Nature. 1993;366:575-580.
3. Pidasheva S, D'Souza-Li L, Canaff L, Cole DE,HendyGN.CASRdb: calcium-sensing receptor locus-specific database for mutations causing familial (benign) hypocalciuric hypercalcemia, neonatal severe hyperparathyroidism, and autosomal dominant hypocalcemia. Hum Mutat. 2004;24:107-111.
4. Lienhardt A, Garabedian M, Bai M, et al. A large homozygous or heterozygous in-frame deletion within the calcium-sensing receptor's carboxylterminal cytoplasmic tail that causes autosomal dominant hypocalcemia. J Clin Endocrinol Metab. 2000;85:1695-1702.
5. Ding C, Buckingham B, Levine MA. Familial isolated hypoparathyroidism caused by a mutation in the gene for the transcription factor GCMB. J Clin Invest. 2001;108:1215-1220.
6. Baumber L, Tufarelli C, Patel S, et al. Identification of a novel mutation disrupting the DNA binding activity of GCM2 in autosomal recessive familial isolated hypoparathyroidism. J Med Genet. 2005; 42:443-448.
7. Thomee C, Schubert SW, Parma J, et al.GCMBmutation in familial isolated hypoparathyroidism with residual secretion of parathyroid hormone. J Clin Endocrinol Metab. 2005;90:2487-2492.
8. Datta R, Waheed A, Shah GN, Sly WS. Signal sequence mutation in autosomal dominant form of hypoparathyroidism induces apoptosis that is corrected by a chemical chaperone. Proc Natl Acad Sci USA. 2007;104:19989-19994.
9. Au AY, McDonald K, Gill A, et al. PTH mutation with primary hyperparathyroidism and undetectable intact PTH. N Engl J Med 2008;359:1184-1186.
10. Lienhardt A, Bai M, Lagarde JP, et al. Activating mutations of the calcium-sensing receptor: management of hypocalcemia. J Clin Endocrinol Metab. 2001;86:5313-5323.
11. Pearce SH, Williamson C, Kifor O, et al. A familial syndrome of hypocalcemia with hypercalciuria due to mutations in the calciumsensing receptor. N Engl J Med. 1996;335:1115-1122.
12. Watanabe S, Fukumoto S, Chang H, et al. Association between activating mutations of calcium-sensing receptor and Bartter's syndrome. Lancet. 2002;360:692-694.
13. Sato K, Hasegawa Y, Nakae J, et al. Hydrochlorothiazide effectively reduces urinary calcium excretion in two Japanese patients with gain-of-function mutations of the calcium-sensing receptor gene. J Clin Endocrinol Metab. 2002;87:3068-3073.
14. Vargas-Poussou R, Huang C, Hulin P, et al. Functional characterization of a calcium-sensing receptor mutation in severe autosomal dominant hypocalcemia with a Bartter-like syndrome. J Am Soc Nephrol. 2002;13:2259-2266.
15. Vezzoli G, Arcidiacono T, Paloschi V, et al. Autosomal dominant hypocalcemia with mild type 5 Bartter syndrome. J Nephrol. 2006; 19:525-528.
16. Okazaki R, Chikatsu N, Nakatsu M, et al. A novel activating mutation in calcium-sensing receptor gene associated with a family of autosomal dominant hypocalcemia. J Clin Endocrinol Metab. 1999; 84:363-366.
17. Chikatsu N, Watanabe S, Takeuchi Y, et al. A family of autosomal dominant hypocalcemia with an activating mutation of calciumsensing receptor gene. Endocr J. 2003;50:91-96.
18. Abdullah HI, Pedraza PL, Hao S, Rodland KD, McGiff JC, Ferreri NR. NFAT regulates calcium-sensing receptor-mediated TNF production. Am J Physiol Renal Physiol. 2006;290:F1110-F1117.
19. Ikari A, Okude C, Sawada H, et al. Activation of a polyvalent cationsensing receptor decreases magnesium transport via claudin-16. Biochim Biophys Acta. 2008;1778:283-290.
20. Weber S, Schneider L, Peters M, et al. Novel paracellin-1 mutations in 25 families with familial hypomagnesemia with hypercalciuria and nephrocalcinosis. J Am Soc Nephrol. 2001;12:1872-1881.
21. Ferre S, Hoenderop JG, Bindels RJ. Sensing mechanisms involved in Ca(2-) and Mg(2-) homeostasis. Kidney Int. 2012;82:1157-1166.